A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries

Background: Despite international initiatives on collaboration within the field of rare diseases, patient access to orphan medicinal products (OMPs) and healthcare services differ greatly between countries. This study aimed to create a comprehensive and in-depth overview of rare diseases policies an...

Descripción completa

Detalles Bibliográficos
Autores principales: Czech, Marcin, Baran-Kooiker, Aleksandra, Atikeler, Kagan, Demirtshyan, Maria, Gaitova, Kamilla, Holownia-Voloskova, Malwina, Turcu-Stiolica, Adina, Kooiker, Coen, Piniazhko, Oresta, Konstandyan, Natella, Zalis'ka, Olha, Sykut-Cegielska, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997877/
https://www.ncbi.nlm.nih.gov/pubmed/32117845
http://dx.doi.org/10.3389/fpubh.2019.00416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997877/
https://www.ncbi.nlm.nih.gov/pubmed/32117845
http://dx.doi.org/10.3389/fpubh.2019.00416

Ejemplares similares